{"id":"https://genegraph.clinicalgenome.org/r/318264ea-b153-4df8-9add-01ddb18f56dcv1.0","type":"EvidenceStrengthAssertion","dc:description":"*ATP13A2* was first reported in relation to autosomal recessive Kufor-Rakeb syndrome in 2006 (Ramirez et al., PMID: 16964263). It was later reported in relation to other autosomal recessive neurodegenerative disorders including hereditary spastic paraplegia, cerebellar ataxia, amyotrophic lateral sclerosis (ALS), and neuronal ceroid lipofuscinosis. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, there is insufficient evidence of a difference in molecular mechanisms or inheritance pattern to explain the wide phenotypic spectrum observed from *ATP13A2* variation; therefore, the Intellectual Disability and Autism Gene Curation Expert Panel decided to lump all these entities together and curate them under the umbrella term Kufor-Rakeb syndrome. \n\nEvidence supporting the relationship between *ATP13A2* and a complex movement disorder includes case-level data, segregation data, and experimental data. For the purposes of this curation, nine variants (missense, splicing, nonsense, and frameshift) reported in seven probands in six publications are included in this curation: (PMIDs: 16964263, 21696388, 27165006, 31944623, 33033738, 30992063). In addition, variants in this gene segregated with disease in at least three families (PMIDs: 11584046, 16964263, 21696388). More genetic evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. \n\nThe mechanism of pathogenicity is known to be bi-allelic loss of function (LoF). This gene-disease association is also supported by animal models and in vitro functional assays (PMIDs: 22647602, 22442086, 23393156, 25855184, 30992063). \n\nIn summary, *ATP13A2* is definitively associated with autosomal recessive Kufor-Rakeb syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on the meeting date April 14, 2022 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/318264ea-b153-4df8-9add-01ddb18f56dc","GCISnapshot":"https://genegraph.clinicalgenome.org/r/0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2022-06-30T17:12:18.562Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2022-04-14T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4dfb815e-4f72-410a-b07e-484012d4b295_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35d5c2cf-aafd-4fb1-b68b-bc5b9aa9a33a","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35d5c2cf-aafd-4fb1-b68b-bc5b9aa9a33a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33033738","allele":{"id":"https://genegraph.clinicalgenome.org/r/09beab6c-4673-4270-882f-a74b04b2f71c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022089.4(ATP13A2):c.2567_2568del (p.Pro856ArgfsTer26)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573105839"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cb5e3a6b-7e9f-4e51-9931-441e6ae980c4","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb5e3a6b-7e9f-4e51-9931-441e6ae980c4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33033738","allele":{"id":"https://genegraph.clinicalgenome.org/r/6bf4ba24-7001-4774-9d86-951cbafe6551","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022089.4(ATP13A2):c.1472_1473del (p.Gln491ArgfsTer29)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA637197"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4dfb815e-4f72-410a-b07e-484012d4b295","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33033738","rdfs:label":"Case 2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":27,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/09beab6c-4673-4270-882f-a74b04b2f71c"},{"id":"https://genegraph.clinicalgenome.org/r/6bf4ba24-7001-4774-9d86-951cbafe6551"}],"detectionMethod":"Recessive ataxia panel","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000605","obo:HP_0001260","obo:HP_0002061","obo:HP_0001347","obo:HP_0007010","obo:HP_0000338","obo:HP_0000709","obo:HP_0011448","obo:HP_0002064","obo:HP_0012444","obo:HP_0002067","obo:HP_0100543","obo:HP_0001251","obo:HP_0002174","obo:HP_0000738"],"previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/cb5e3a6b-7e9f-4e51-9931-441e6ae980c4_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/35d5c2cf-aafd-4fb1-b68b-bc5b9aa9a33a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/e80a06de-aea6-40f8-a33a-d3ff1bad80e4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2c749c1-827a-4a03-ae77-ea55f58023ac","type":"EvidenceLine","dc:description":"Downgraded due to homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2c749c1-827a-4a03-ae77-ea55f58023ac_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"injection of ATP13A2:Gln613* construct failed to rescue the cerebellar integrity or motor neuron extension phenotype of the atp13a2 knock down phenotype in zebrafish","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/b2c749c1-827a-4a03-ae77-ea55f58023ac_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30992063","allele":{"id":"https://genegraph.clinicalgenome.org/r/e59726a7-3c42-4cd5-ad1d-a8860062b9d9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022089.4(ATP13A2):c.1837C>T (p.Gln613Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338246668"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e80a06de-aea6-40f8-a33a-d3ff1bad80e4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30992063","rdfs:label":"MA80","ageType":"AgeAtReport","ageUnit":"Years","ageValue":32,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e59726a7-3c42-4cd5-ad1d-a8860062b9d9"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"pyramidal syndrome","phenotypes":["obo:HP_0001324","obo:HP_0001618","obo:HP_0002015","obo:HP_0002066","obo:HP_0001256","obo:HP_0002063","obo:HP_0002061","obo:HP_0001258"],"previousTesting":true,"previousTestingDescription":"Targeted testing for SOD1, FUS, TARDBP, ALS2, C9orf72, SPG11, SPG14, SCA1, and SCA2. No disease-causative changes were detected","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b2c749c1-827a-4a03-ae77-ea55f58023ac_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ddd0e08b-5daf-4c39-8c14-efc0c5dc7771_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bdab73f-47bb-4b8d-9d5e-38c64599e3c2","type":"EvidenceLine","dc:description":"Downgraded because homozygous variant in a consanguineous family","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bdab73f-47bb-4b8d-9d5e-38c64599e3c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16964263","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd0d7310-dffb-4505-8a8d-31f5d67978d5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ATP13A2, 22-BP DUP","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1220"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ddd0e08b-5daf-4c39-8c14-efc0c5dc7771","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16964263","rdfs:label":"V-49","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/dd0d7310-dffb-4505-8a8d-31f5d67978d5"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"mask-like-face","phenotypes":["obo:HP_0002385","obo:HP_0001257","obo:HP_0002067","obo:HP_0002375","obo:HP_0002063","obo:HP_0000726","obo:HP_0012444","obo:HP_0000605"],"previousTesting":true,"previousTestingDescription":"Linkage Analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7bdab73f-47bb-4b8d-9d5e-38c64599e3c2_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2020d249-d395-4809-84a5-f679e3174ed6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca686229-250b-45ad-a00b-34fe1b2ab9c0","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca686229-250b-45ad-a00b-34fe1b2ab9c0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27165006","allele":{"id":"https://genegraph.clinicalgenome.org/r/0a7e368a-9695-4763-a2f5-4090933e8d52","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022089.4(ATP13A2):c.2675G>A (p.Gly892Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA636737"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/2020d249-d395-4809-84a5-f679e3174ed6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27165006","rdfs:label":"Patient 17","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0a7e368a-9695-4763-a2f5-4090933e8d52"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002510","obo:HP_0002067","obo:HP_0002063","obo:HP_0000605","obo:HP_0001268","obo:HP_0000514","obo:HP_0001260","obo:HP_0002943","obo:HP_0002015","obo:HP_0002064","obo:HP_0001300"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ca686229-250b-45ad-a00b-34fe1b2ab9c0_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/fa0713ce-bf6d-48d3-90dc-892b1009589e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9764a9b4-0ee7-490b-ad71-131e49e09b17","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9764a9b4-0ee7-490b-ad71-131e49e09b17_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31944623","allele":{"id":"https://genegraph.clinicalgenome.org/r/f863a81d-1dfb-4017-b9cd-85070a216da6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022089.4(ATP13A2):c.2158G>T (p.Gly720Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338243709"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/fa0713ce-bf6d-48d3-90dc-892b1009589e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31944623","rdfs:label":"Patient C","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":29,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f863a81d-1dfb-4017-b9cd-85070a216da6"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001258","obo:HP_0012444","obo:HP_0002015","obo:HP_0000514","obo:HP_0011448","obo:HP_0001260","obo:HP_0007340","obo:HP_0002061","obo:HP_0000365","obo:HP_0001256","obo:HP_0001251","obo:HP_0000725","obo:HP_0002352"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9764a9b4-0ee7-490b-ad71-131e49e09b17_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/9673a70d-73aa-4883-b8fe-d36c9df35c4d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d471c8eb-aab1-4e82-a693-7234bd672e97","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d471c8eb-aab1-4e82-a693-7234bd672e97_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"cDNA analysis from the father and two affected children confirmed that the c.1306+5G>A splice site variant causes in-frame skipping of exon 13 (removing 111 nucleotides). ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d471c8eb-aab1-4e82-a693-7234bd672e97_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16964263","allele":{"id":"https://genegraph.clinicalgenome.org/r/eef43429-5714-481e-87e6-4e1bfd3e1821","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022089.4(ATP13A2):c.1306+5G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251715"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0fd9aa97-bc24-4ac5-b48e-58ca71048513","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0fd9aa97-bc24-4ac5-b48e-58ca71048513_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16964263","allele":{"id":"https://genegraph.clinicalgenome.org/r/621ad036-53e0-4f68-b61e-50d74ab99905","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022089.4(ATP13A2):c.3057del (p.Tyr1020fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA636632"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9673a70d-73aa-4883-b8fe-d36c9df35c4d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16964263","rdfs:label":"II-8","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":18,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/621ad036-53e0-4f68-b61e-50d74ab99905"},{"id":"https://genegraph.clinicalgenome.org/r/eef43429-5714-481e-87e6-4e1bfd3e1821"}],"detectionMethod":"sequenced all 29 exons and splice sites of the predicted gene ATP13A2 ","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0000605","obo:HP_0012378","obo:HP_0007256","obo:HP_0001268","obo:HP_0002067","obo:HP_0001336","obo:HP_0002063","obo:HP_0002322"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d471c8eb-aab1-4e82-a693-7234bd672e97_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0fd9aa97-bc24-4ac5-b48e-58ca71048513_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4bef14a-6ce2-4db8-9db7-5fd42f22466c_proband_segregation","type":"FamilyCosegregation","dc:description":"Autosomal recessive condition with 5 affetced family members ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16964263","rdfs:label":"Jordanian","estimatedLodScore":2.53,"family":{"id":"https://genegraph.clinicalgenome.org/r/d4bef14a-6ce2-4db8-9db7-5fd42f22466c","type":"Family","rdfs:label":"Jordanian","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ddd0e08b-5daf-4c39-8c14-efc0c5dc7771"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"mask-like-face","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0002063","obo:HP_0012444","obo:HP_0002067","obo:HP_0000726","obo:HP_0002385","obo:HP_0000605","obo:HP_0002375","obo:HP_0001257"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/ddd0e08b-5daf-4c39-8c14-efc0c5dc7771"},"publishedLodScore":2.57,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/1f36b9ee-238f-4a5d-be5a-41ca03d7b7c5_proband_segregation","type":"FamilyCosegregation","dc:description":"Autosomal Recessive disease with greater than 3 affected family members","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21696388","rdfs:label":"Inuit","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/1f36b9ee-238f-4a5d-be5a-41ca03d7b7c5","type":"Family","rdfs:label":"Inuit","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7efa5499-7a31-4148-9689-24df7c60c4bf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21696388","rdfs:label":"V-I","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f0795498-a179-4b9f-af28-7b14eed8932e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022089.4(ATP13A2):c.2473delinsAA (p.Leu825AsnfsTer33)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573105805"}},"detectionMethod":"Whole gene sequencing","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0002067","obo:HP_0000738","obo:HP_0001251","obo:HP_0000709","obo:HP_0002063","obo:HP_0001257","obo:HP_0002385","obo:HP_0001347","obo:HP_0000605","obo:HP_0001336"],"previousTesting":false,"previousTestingDescription":"Mutations in the genes HTT, ATN1, ATXN1, ATXN2, ATXN3, CACNA1A, ATXN7, TBP, TOR1A, GCH1, SGCE, FRDA, MAPT, PRGN, PS1, PS2, and APP were excluded by fragment analyses or direct sequencing","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3a90b0d9-d0c4-409b-beb9-e7e4c4fd4115_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21696388","allele":{"id":"https://genegraph.clinicalgenome.org/r/f0795498-a179-4b9f-af28-7b14eed8932e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0000738","obo:HP_0001347","obo:HP_0001268","obo:HP_0000709","obo:HP_0001251","obo:HP_0000605","obo:HP_0001257","obo:HP_0001336","obo:HP_0002063","obo:HP_0002067"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7efa5499-7a31-4148-9689-24df7c60c4bf"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e1e68317-3d55-43a1-a46b-934cd937aeed_proband_segregation","type":"FamilyCosegregation","dc:description":"Recessive disorder with 4 affected","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16964263","rdfs:label":"Chilean","estimatedLodScore":2.68,"family":{"id":"https://genegraph.clinicalgenome.org/r/e1e68317-3d55-43a1-a46b-934cd937aeed","type":"Family","rdfs:label":"Chilean","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9673a70d-73aa-4883-b8fe-d36c9df35c4d"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":7,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0000605","obo:HP_0001336","obo:HP_0002067","obo:HP_0002322","obo:HP_0002063","obo:HP_0001268","obo:HP_0007256","obo:HP_0012378"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9673a70d-73aa-4883-b8fe-d36c9df35c4d"},"publishedLodScore":2.68,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7efa5499-7a31-4148-9689-24df7c60c4bf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a90b0d9-d0c4-409b-beb9-e7e4c4fd4115","type":"EvidenceLine","dc:description":"Score reduced due to homozygous variant in a consanguineous family","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a90b0d9-d0c4-409b-beb9-e7e4c4fd4115_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7efa5499-7a31-4148-9689-24df7c60c4bf"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01d8d8f4-3dea-47cc-9d1a-cef30e95ea69","type":"EvidenceLine","dc:description":"Non-specific phenotype","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03766fb0-b046-48b7-865f-774c379e8684","type":"Finding","dc:description":"KO mice exhibit late onset motor deficits similar (but not specific) to the deficits seen in patients. Most specific smililarity in phenotype was with lipofuscinosis accumulation in the brain. Howver this has only been reproted in one patient (PMID: 22388936).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25855184","rdfs:label":"Mouse Modle_Sanchiz-Calvo","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ba82bfb3-6369-4097-b9eb-ed19871da98a","type":"EvidenceLine","dc:description":"Phenotype is non-specific","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b08fd18d-af48-4b34-b468-cbfdc7b94364","type":"Finding","dc:description":"KO mice exhibit late onset (20-29) motor and congnative deficits similar (but not specific) to the deficits seen in patients. Most specific smililarity in phenotype was with lipofuscinosis accumulation in the brain. Howver this has only been reproted in one patient (PMID: 22388936)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23393156","rdfs:label":"Mouse Modle_Schultheis","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/41cbf7e9-1c2c-41cd-8b7d-6f089b66527e","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c35ea517-203d-4960-a633-c3658658b00c","type":"Finding","dc:description":"co-injection of embryos with WT ATP13A2 rescued the cerebellum formation defects and the motor neuron extension defects\n\nco-injection of embryos with with the ATP13A2:p.Glu613* or ATP13A2:p.Gly504Arg constructs did not rescue the phenotype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30992063","rdfs:label":"Zebrafish knowckdown study","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/257cbc8e-ad07-4bf9-aa8e-f53738299c4f","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7694809e-2ddb-4274-bbd1-3687022ff589","type":"FunctionalAlteration","dc:description":"General lysosomal deficiency in ATP13A2 patient fibroblasts:\nAccumulation of lysosomal-related structures in patient fibroblasts\nLysosomal pH acidification was compromised in patient\nImpaired lysosomal protolysis in patient fibroblasts\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22647602","rdfs:label":"Patient Fibroblast Study"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/54130595-a6d6-462b-8336-fe87890a4af4","type":"EvidenceLine","dc:description":"Same patient cell line used in Dehay (2012) PMID: 22647602 (which was scored). Results are similar and thus corroborate the findings in Dehay (2012) PMID: 22647602, but do not provide new evidence\n","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13571371-35c1-481f-8c40-2e6a4ff77a72","type":"FunctionalAlteration","dc:description":"General lysosomal deficiency in ATP13A2 patient fibroblasts: \nAccumulation of lysosomal-related structures in patient fibroblasts \nImpaired lysosomal protolysis in patient fibroblasts","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22442086","rdfs:label":"Patient Fibroblast Study"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0b69a102-bcaf-41a3-be91-e240f321166f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2fc2242c-4373-4fc5-9748-2560226d0a94","type":"FunctionalAlteration","dc:description":"General lysosomal deficiency in ATP13A2 KD neuroblastoma cells: \nAccumulation of lysosomal-related structures ATP13A2 KD neuroblastoma cells\nLysosomal pH acidification was compromised ATP13A2 KD neuroblastoma cells\nImpaired lysosomal proteolysis in ATP13A2 KD neuroblastoma cells\nIncreased cell death in ATP13A2 KD neuroblastoma cells\nPhenotypes were partially rescuded by overexpression of WT-ATP13A2","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22647602","rdfs:label":"Knockdown in neuroblastoma cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a0455f2-2e24-4105-9d6d-1de93b90970f","type":"EvidenceLine","dc:description":"Expression is brian is non-specific","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2cf5d15-1c1b-4a8a-a96d-afab89fb5e9c","type":"Finding","dc:description":"Human multiple-tissue RNA and dot blots in adult and fetal brain(BD Biosciences Clontech) show ubiquitous ATP13A2 expression with highest expression in brain and all tested brain subregions, including fetal brain. In situ hybridization of adult mouse brain shows broad central nervous system expression of Atp13a2","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16964263","rdfs:label":"RNA studies","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":4693,"specifiedBy":"GeneValidityCriteria8","strengthScore":17.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/XT6Fv9nd6zM","type":"GeneValidityProposition","disease":"obo:MONDO_0011706","gene":"hgnc:30213","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_0ba5cb4f-3f7f-44dc-b2a5-0a2d62e510d4-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}